About this trial
Study design: prospective, single arm.
Objectives: survey lung cancer detection rate of low-dose computed tomography (LDCT) screening in individuals who had never smoked.
Participants will undergo questionnaires, and collecting specimens including blood, urine, and medical informations including results of pulmonary function tests, and LDCT screening upon inclusion. The participants will be followed up according to current standards of clinical practice.
Eligibility criteria
Qualifiers
Individuals with no history of smoking.
Aged 40 to 80 years.
Willing to provide written informed consent and complete questionnaire assessments.
After undergoing examinations, willing to provide relevant biological information, including but not limited to: blood samples, urine samples, pulmonary function test results, imaging data, and tissue specimens obtained from invasive biopsies or surgical procedures (if applicable).
Disqualifiers
History of lung cancer, or a diagnosis of any malignancy other than skin cancer or cervical carcinoma in situ within the past five years.
Undergoing chest computed tomography (CT) scans within the past 18 months.
Unexplained hemoptysis within the past one month.
Unexplained weight loss exceeding 6 kilograms within the past one year.
Trial design
Treatments tested in this trial
- Low dose computed tomography
Treatment groups
Locations
Sponsors and collaborators
Chung Shan Medical University
Lead sponsor
Ministry of Health and Welfare, Taiwan
Collaborator